I've followed Evogene and posted about them from time to time, most recently in #msg-92307662. EVGN has a partnership with MON, one of my largest holdings, and I like ag stocks in general.
Evogene is one of the best performers among bio comps on TASE and is call 'the better half of Compugen' :-) I like them but don't have the skills to really understand their platform, but MON seems to believe in their abilities and has a 8.6% stake in EVGN and this could increase to 9.4% after EVGN's US IPO, upper limit price for MON is $17/share.